Clinical Trials · NCT00463983
Treatment of Idiopathic Pulmonary Fibrosis With Long Acting Octreotide
- Phase
- Phase 1/Phase 2
- Recruitment status
- Completed
- Sponsor
- Institut National de la Santé Et de la Recherche Médicale, France
- Enrollment
- 25
- Start date
- Oct 2006
- Locations
- 16 sites, France
- Primary endpoint
- FVC changes